http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101281196-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c0ed78c4d5c4951a22374d61ea1f178 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b64139444fa240c2c1b59deb9c7617a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ef8c4e306335b909b68777c792c95fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e22e8ad17e092dfd42f21dc0dc4ef08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e5820123d65aa1fe0ed0664666e71ad |
| publicationDate | 2008-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101281196-A |
| titleOfInvention | HIV-1 p24 antigen acridine ester chemiluminescence immune analyse detecting method |
| abstract | HIV-1 p24 antigen acridine ester chemiluminescence immunity analyzing testing method pertains to the clinical blood testing analysis method technique field. The prior HIV-1 p24 antigen testing method has problems of low sensitivity, rigmarole operations and the like. The invention uses acridine ester series compounds to mark the HIV-1 p24 antibody, adopts a double antibody/antigen sandwich method to execute immunity combination between the p24 antigen-antibody; uses excitant hydrogen peroxide, nitric acid, Triton X-100, and sodium hydrate to excite acridine ester series compounds to execute chemiluminescence reaction; and tests the number of photon to execute a qualitative and/or quantitative analysis. The invention has good correlativity with the general ELISA testing method, which has a correlation coefficient of 0.951 at the instance of P no more than 0.01; has high sensitivity, wherein, the testing limit is 0.5pg/ml; has wide detection range in 5-6 magnitude order; and the invention also has advantages of short reaction time, easier operation and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108226483-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107247135-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105652018-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104280542-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108226483-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104697830-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106645756-A |
| priorityDate | 2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.